Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: 1st Biosimilar of Dornase Alfa Inhalation Solution for CF Approved in Russia, Companies Announce Progress for Cystic Fibrosis [INFOGRAPHIC] 1st Biosimilar of Dornase Alfa Inhalation Solution for CF Approved in Russia, Companies Announce Sep 19, 2019 07:00 am | Steve Bryson PhD A biosimilar of dornase alfa inhalation solution, with the same therapeutic activity as Pulmozyme, its reference therapy, was approved for use in Russia, Selexis and Generium Pharmaceutical announced.  A biosimilar is like a generic formulation of an approved biological treatment in that it is clinically similar to its reference medicine.  Named Tigerase, this is the first dornase alfa […] The post 1st Biosimilar of Dornase Alfa Inhalation Solution for CF Approved in Russia, Companies Announce appeared first on Cystic Fibrosis News Today. Read More Progress for Cystic Fibrosis [INFOGRAPHIC] Sep 18, 2019 01:33 pm | Patricia Silva, PhD Share this infographic on your site! Please include attribution to www.cysticfibrosisnewstoday.com with this graphic. https://cysticfibrosisnewstoday.com/2019/09/18/progress-for-cystic-fibrosis-infographic/’>https://cysticfibrosisnewstoday.com/wp-content/uploads/2019/09/CFinfov3.png

’ alt=’Cystic Fibrosis News Today Infographic’ width=’600px’ border=’0′ />







The following figures were […]
The post Progress for Cystic Fibrosis [INFOGRAPHIC] appeared first on Cystic Fibrosis News Today.

Read More

Recent News

Translate Bio Prioritizes Development of CF Therapy MRT5005, Other Lung Disease Candidates
Prenatal Testing for Cystic Fibrosis Influences Pregnancy Outcomes, Review Finds
Our Colons Need Your Help
Reflecting on the First Year of My Column, ‘Mutations & Conversations’
Armata Announces New Treatment Candidate for P. Aeruginosa Infections in CF Patients